Long-term percutaneous catheter inserted into a polytetrafluoroethylene graft for administration of chemotherapy.
Long-term percutaneous catheter inserted into a polytetrafluoroethylene graft for administration of chemotherapy.
复制标题
长期经皮导管插入聚四氟乙烯移植物中用于化疗。
DOI：
10.1001/archsurg.1982.01380280092020
复制
发表时间：
1982
影响因子：
--
通讯作者：
J. Ennis
中科院分区：
文献类型：
--
作者：
J. Raaf;J. Ennis
对癌症患者进行长期、间歇性的化疗往往是困难的，因为以前曾用抗肿瘤药物使外周表面静脉硬化。然后，患者在每次接受化疗时都会接受几次失败的静脉穿刺术，并增加了渗出的风险，随后会造成组织损伤。我们用了两种方法来解决这个问题。静脉较差的患者在门诊或住院期间可能需要长期(六个月或更长时间)进行化疗，可以接受Broviac(或Hickman)中心静脉导管(尤其对儿童有用[B.Eisenberg，MD，P.R.Exelby，MD，J.H.RAAF，MD，未发表的观察])，或在手臂或腿部植入聚四氟乙烯(PTFE)动静脉移植物。1在这两种技术之间进行选择可能很困难，这取决于患者的可靠性、管理导管并发症的人员的可用性以及
To the Editor .—Long-term, intermittent administration of chemotherapy to patients with cancer is often difficult due to previous sclerosis of the peripheral surface veins by antineoplastic agents. Patients are then subjected to several unsuccessful attempts at venipuncture each time they receive chemotherapy and are at increased risk for extravasation, with subsequent tissue damage. We have used two methods to solve this problem. A patient with poor veins who is likely to require chemotherapy on a long-term basis (six months or more) as an outpatient or inpatient receives either a Broviac (or Hickman) central venous catheter (useful especially in children [B. Eisenberg, MD, P. R. Exelby, MD, J. H. Raaf, MD, unpublished observation]), or a polytetrafluoroethylene (PTFE) arteriovenous graft placed in the arm or leg. 1 The choice between these two techniques may be difficult, and depends on such factors as patient reliability, availability of personnel to manage catheter complications, and